Summit Global Investments - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 130 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,667
+46.2%
36,238
+82.6%
0.11%
+48.0%
Q2 2023$1,140
-18.5%
19,844
-46.8%
0.08%
-30.6%
Q1 2023$1,399
+69.2%
37,300
+26.4%
0.11%
+54.3%
Q4 2022$827
-99.9%
29,500
+46.8%
0.07%
+34.6%
Q3 2022$565,000
-69.5%
20,100
-62.2%
0.05%
-68.1%
Q2 2022$1,851,000
+15.3%
53,214
+19.0%
0.16%
+38.1%
Q1 2022$1,605,000
+50.1%
44,700
-2.6%
0.12%
+71.0%
Q4 2021$1,069,000
-7.0%
45,900
-24.1%
0.07%
-19.8%
Q3 2021$1,150,000
+20.3%
60,500
+27.6%
0.09%
+50.9%
Q2 2021$956,000
+9.8%
47,400
-0.3%
0.06%
+1.8%
Q1 2021$871,000
-30.5%
47,546
-23.8%
0.06%
-55.2%
Q4 2020$1,254,000
+6.2%
62,379
-1.0%
0.12%
+2.5%
Q3 2020$1,181,000
-15.8%
62,992
+0.9%
0.12%
-24.7%
Q2 2020$1,402,000
+61.1%
62,440
+6.5%
0.16%
+27.6%
Q1 2020$870,000
-8.0%
58,640
+19.6%
0.13%
+23.3%
Q4 2019$946,000
+11.7%
49,040
+14.8%
0.10%
+5.1%
Q3 2019$847,00042,7250.10%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders